CRTC1 and metabolic dysfunction-associated steatotic liver disease: We identified that CRTC1, a member of the family of CRTC transcription co-factors, exhibited great potential for alleviating various pathological lipid accumulation and inflammation underlying NAFLD development, and selected it for further study.